Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 36 studies | 44% ± 21% | |
pericyte | 36 studies | 67% ± 26% | |
smooth muscle cell | 34 studies | 80% ± 24% | |
myofibroblast cell | 16 studies | 78% ± 19% | |
connective tissue cell | 14 studies | 43% ± 25% | |
endothelial cell | 14 studies | 32% ± 14% | |
non-classical monocyte | 6 studies | 25% ± 11% | |
basal cell | 6 studies | 37% ± 16% | |
type I pneumocyte | 5 studies | 27% ± 9% | |
endothelial cell of artery | 5 studies | 24% ± 5% | |
myoepithelial cell | 5 studies | 68% ± 24% | |
endothelial cell of vascular tree | 5 studies | 41% ± 32% | |
mesothelial cell | 4 studies | 30% ± 6% | |
adventitial cell | 4 studies | 38% ± 12% | |
vein endothelial cell | 3 studies | 18% ± 2% | |
macrophage | 3 studies | 28% ± 16% | |
adipocyte | 3 studies | 20% ± 1% | |
muscle cell | 3 studies | 79% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 86% | 118548.03 | 210 / 245 | 100% | 414.48 | 500 / 502 |
breast | 83% | 44796.85 | 382 / 459 | 94% | 129.27 | 1049 / 1118 |
bladder | 90% | 137694.71 | 19 / 21 | 73% | 111.26 | 370 / 504 |
uterus | 97% | 202987.75 | 165 / 170 | 62% | 169.95 | 284 / 459 |
intestine | 75% | 167751.36 | 727 / 966 | 75% | 86.99 | 395 / 527 |
lung | 60% | 27336.24 | 347 / 578 | 84% | 85.54 | 975 / 1155 |
stomach | 48% | 68478.93 | 174 / 359 | 79% | 125.66 | 227 / 286 |
esophagus | 71% | 164662.49 | 1022 / 1445 | 55% | 48.12 | 100 / 183 |
ovary | 54% | 36168.79 | 98 / 180 | 66% | 57.03 | 285 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.63 | 1 / 1 |
blood vessel | 100% | 374026.27 | 1332 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 95% | 214.16 | 169 / 178 |
thymus | 25% | 10970.34 | 161 / 653 | 62% | 31.39 | 374 / 605 |
kidney | 22% | 11104.83 | 20 / 89 | 62% | 64.96 | 561 / 901 |
adipose | 79% | 49150.26 | 954 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 10% | 3304.22 | 25 / 258 | 57% | 50.50 | 130 / 230 |
skin | 11% | 4551.33 | 205 / 1809 | 39% | 18.48 | 183 / 472 |
lymph node | 0% | 0 | 0 / 0 | 45% | 17.55 | 13 / 29 |
tonsil | 0% | 0 | 0 / 0 | 38% | 21.18 | 17 / 45 |
liver | 2% | 703.35 | 4 / 226 | 36% | 18.09 | 145 / 406 |
brain | 0% | 237.32 | 12 / 2642 | 35% | 23.20 | 247 / 705 |
heart | 27% | 12264.08 | 233 / 861 | 0% | 0 | 0 / 0 |
spleen | 13% | 5336.49 | 31 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 1.00 | 3 / 80 |
muscle | 2% | 1064.35 | 19 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | TAGLN |
Protein name | Transgelin Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha) (SM22-alpha) |
Synonyms | hCG_2032895 DKFZp686P11128 SM22 WS3-10 |
Description | FUNCTION: Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence. . |
Accessions | Q01995 Q5U0D2 Q6FI52 ENST00000532870.5 ENST00000529792.5 ENST00000529622.1 ENST00000530649.5 ENST00000392951.9 B0YJ58 ENST00000278968.10 E9PJ32 H0YCU9 ENST00000525531.5 |